Active, Not Recruiting
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
NCT04704921
- Conditions
- AMD, CNV, Choroid Diseases, +18 more
- Locations
-
- Retinal Research Institute /ID# 256019 Phoenix, Arizona, United States
- Barnet Dulaney Perkins Eye Center - Sun City /ID# 256055 Sun City, Arizona, United States
- University of Arkansas for Medical Sciences /ID# 271290 Little Rock, Arkansas, United States
- Retina Vitreous Assoc Med Grp /ID# 256299 Beverly Hills, California, United States